DK1200115T3 - Erythropoietinformuleringer af multidosistypen - Google Patents

Erythropoietinformuleringer af multidosistypen

Info

Publication number
DK1200115T3
DK1200115T3 DK00960177T DK00960177T DK1200115T3 DK 1200115 T3 DK1200115 T3 DK 1200115T3 DK 00960177 T DK00960177 T DK 00960177T DK 00960177 T DK00960177 T DK 00960177T DK 1200115 T3 DK1200115 T3 DK 1200115T3
Authority
DK
Denmark
Prior art keywords
informations
type erythropoietin
multidose type
multidose
erythropoietin
Prior art date
Application number
DK00960177T
Other languages
English (en)
Inventor
Atef Gayed
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK1200115T3 publication Critical patent/DK1200115T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK00960177T 1999-07-22 2000-07-21 Erythropoietinformuleringer af multidosistypen DK1200115T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19821699P 1999-07-22 1999-07-22

Publications (1)

Publication Number Publication Date
DK1200115T3 true DK1200115T3 (da) 2006-01-16

Family

ID=22732468

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00960177T DK1200115T3 (da) 1999-07-22 2000-07-21 Erythropoietinformuleringer af multidosistypen

Country Status (25)

Country Link
US (1) US7432360B2 (da)
EP (1) EP1200115B9 (da)
JP (1) JP2003517462A (da)
KR (1) KR100693263B1 (da)
CN (2) CN1371284A (da)
AT (1) ATE304863T1 (da)
AU (1) AU777397B2 (da)
BR (1) BR0012667A (da)
CA (1) CA2378945C (da)
CZ (1) CZ302750B6 (da)
DE (1) DE60022759T2 (da)
DK (1) DK1200115T3 (da)
EA (1) EA006220B1 (da)
EE (1) EE200200037A (da)
ES (1) ES2248110T3 (da)
HK (1) HK1050318A1 (da)
HR (1) HRP20020159B1 (da)
HU (1) HUP0202246A3 (da)
IL (2) IL147755A0 (da)
NO (1) NO20020303L (da)
NZ (1) NZ516735A (da)
PL (1) PL202945B1 (da)
RS (1) RS50355B (da)
WO (1) WO2001007075A2 (da)
ZA (1) ZA200200742B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1371287A (zh) 1999-07-22 2002-09-25 阿温蒂斯药物公司 防腐的药物制剂
JP3967594B2 (ja) 2000-05-15 2007-08-29 エフ．ホフマン−ラ ロシュ アーゲー 新しい薬剤組成物
UA89630C2 (ru) * 2004-03-26 2010-02-25 Янссен Фармацевтика Н.В. Схема комбинированного дозирования для эритропоэтина
US7772182B2 (en) 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
US8877234B2 (en) * 2005-02-03 2014-11-04 Clariant Finance (Bvi) Limited Preservatives
JP2011116752A (ja) * 2009-10-29 2011-06-16 Jcr Pharmaceuticals Co Ltd エリスロポエチン含有水性液剤
KR101805087B1 (ko) 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
CA3001429C (en) * 2015-10-22 2023-07-11 Iltoo Pharma Pharmaceutical compositions of il-2

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489837A (en) * 1968-07-11 1970-01-13 Leroy J Hyman Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
JPS6191131A (ja) * 1984-10-09 1986-05-09 Chugai Pharmaceut Co Ltd 医薬品の吸着防止方法および組成物
JPS6197229A (ja) 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0651637B2 (ja) * 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
CA2050425A1 (en) * 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
JP2532025B2 (ja) * 1993-07-23 1996-09-11 株式会社林原生物化学研究所 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
US5968899A (en) * 1994-06-03 1999-10-19 Tsumura & Co. Medicinal compositions of peptides with EACA or tranexamic acid for enhanced mucosal absorption
JP2000504319A (ja) * 1996-01-19 2000-04-11 イーライ・リリー・アンド・カンパニー 肥満症タンパク質製剤
CN1233963A (zh) * 1996-09-13 1999-11-03 有限会社最先端医学研究所 神经营养因子的眼科用组合物、视神经机能障碍治疗药和视神经机能障碍治疗方法
JPH1112193A (ja) * 1997-06-19 1999-01-19 Sankyo Co Ltd ヒトカルシトニン含有水溶液製剤
GB9726555D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Vaccine

Also Published As

Publication number Publication date
EP1200115B9 (en) 2006-01-18
HUP0202246A3 (en) 2010-01-28
IL147755A0 (en) 2002-08-14
BR0012667A (pt) 2002-07-02
EA200200073A1 (ru) 2002-08-29
ATE304863T1 (de) 2005-10-15
KR20020011143A (ko) 2002-02-07
HUP0202246A2 (en) 2002-10-28
US7432360B2 (en) 2008-10-07
EP1200115B1 (en) 2005-09-21
YU4702A (sh) 2005-06-10
US20050267033A1 (en) 2005-12-01
RS50355B (sr) 2009-11-10
WO2001007075A2 (en) 2001-02-01
JP2003517462A (ja) 2003-05-27
CN101091792A (zh) 2007-12-26
HK1050318A1 (zh) 2003-06-20
AU7137400A (en) 2001-02-13
CZ2002264A3 (cs) 2002-06-12
NO20020303L (no) 2002-03-21
HRP20020159B1 (en) 2007-08-31
EA006220B1 (ru) 2005-10-27
AU777397B2 (en) 2004-10-14
PL202945B1 (pl) 2009-08-31
KR100693263B1 (ko) 2007-03-13
CZ302750B6 (cs) 2011-10-19
NO20020303D0 (no) 2002-01-21
CA2378945C (en) 2010-02-23
IL147755A (en) 2009-11-18
CA2378945A1 (en) 2001-02-01
ZA200200742B (en) 2003-06-25
ES2248110T3 (es) 2006-03-16
PL353569A1 (en) 2003-12-01
HRP20020159A2 (en) 2003-06-30
CN1371284A (zh) 2002-09-25
DE60022759T2 (de) 2006-06-22
WO2001007075A3 (en) 2001-10-04
DE60022759D1 (de) 2006-02-02
EP1200115A2 (en) 2002-05-02
EE200200037A (et) 2003-04-15
NZ516735A (en) 2004-01-30

Similar Documents

Publication Publication Date Title
MXPA00007404A (es) Composiciones de champu estilizantes.
ID22240A (id) Komposisi shampoo penataan rambut dengan deposisi polimer penataan rambut yang ditingkatkan
DE60124152D1 (de) Kosmetische zusammensetzungen enthaltend siloxancopolymer-netzwerke
DK0895776T3 (da) Kosmetisk, lysskærmende præparat
DE69929463D1 (de) Polyhydroxylierte heterocyclische derivate als antikoagulanten
ATE228111T1 (de) M-amidinophenyl-analoga als faktor-xa-inhibitoren
DE69941116D1 (de) G von gdf-8
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK1200115T3 (da) Erythropoietinformuleringer af multidosistypen
EE200100131A (et) Süstelahuste parem stabiilsus
DE69616074T2 (de) Ara-c derivate
DE59912915D1 (de) Herstellung von 4,4'-Diketo-carotinoiden
DE69935165D1 (de) Herstellung von polyolefin
DE59909255D1 (de) Kosmetische zubereitungen
DK0941081T3 (da) Ny anvendelse af creatin
DE60142107D1 (de) Monopolarer Satz von Direkt-Methanol-Brennstoffzellen
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ATE212335T1 (de) 3-mercapto-2-alkyl-alkan-1-ole und ihre anwendung als duft- und aromastoffe
DE69705849D1 (de) Herstellung von 3,5-lutidin
EA200100073A1 (ru) Изохинолины в качестве ингибиторов урокиназы
DK1173065T3 (da) Anvendelse af cellulosemikrofibriller i fermenterede mælkepræparater
FR2752699B1 (fr) Boitier, du type boitier de maquillage
DE69931182D1 (de) Verwendung von triclosan als antimalariamittel
SE9600984D0 (sv) Gällande ny typ av elektroakustisk omvandlare, s k mikrofon